The global Sulfasalazine Market is estimated to be valued at US$ 2.01 billion in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Sulfasalazine is a disease-modifying anti-rheumatic drug (DMARD) used in the treatment of various inflammatory conditions, such as rheumatoid arthritis ... Read more
